It may have been a long time coming but mental health has never been more in the spotlight here in Canada than it is right now.

Efforts to remove stigma surrounding mental issues have become massive, nation-wide initiatives helping thousands address what may be impacting them. According to the Anxiety Disorders Association of Canada, 1 in 4 Canadians will experience “at least one anxiety disorder in their lifetime.” Some may turn to professional help, however many more will not.

Thankfully though, one little dietary change could be enough to help some light shine through the dark cloud anxiety and depression can bring. Science has clearly shown Omega-3 supplements like SeaDNA Omega-3 Seal Oil can have a positive impact.

So if someone in your life is dealing with issues of anxiety or depression, taking SeaDNA Omega-3 Seal Oil could make a major difference.


A recent compilation of 19 clinical studies on the issue was published in the Journal of the American Medical Association (JAMA) recently and among the findings quoted was:
– Clinical trials have found a link between those who have low Omega-3 levels and mental health issues.
– Omega-3 supplements can reduce anxiety and depression in patients with low Omega-3 levels.

Back here in Canada researchers have also been looking into the issue and found similar results. Scientists from Quebec and Ontario studied over 400 Canadians for four years and determined Omega-3 supplements are effective at fighting symptoms of anxiety and depression.


So now that we have determined Omega-3 supplements could help – why is SeaDNA Omega-3 Seal Oil a good choice?

First, there is the unique power seal oil brings thanks to its third fatty-acid called DPA. DPA is a super-hero of an Omega-3 that fish oil supplements do not have in high quantities. It is the natural presence of DPA in balanced quantities with EPA and DHA that makes SeaDNA Seal Oil the most complete, and perhaps, most effective Omega-3 on the market.


Quebec-based researcher Caroline Morin and her team have found DPA to be very potent in helping our body restore a healthy Omega-3/6 ratio. As we age, our body naturally shifts to a more Omega-6 heavy diet which can throw things out of whack internally. Adding Omega-3 to our diet is the only way to revert this change.

Many Canadians currently choose fish oil for their Omega-3 needs. It delivers EPA and DHA: two key fatty acids that do wonders in the body. However, SeaDNA Seal Oil doesn’t just have EPA and DHA, it has the added power of DPA.


Along with the presence of DPA, SeaDNA Seal Oil is also more efficient and more easily digested than alternatives. The fact the seal is a mammal also means our bodies naturally integrate the Omega-3 content faster. We handle the familiar mammal cellular make-up of seal oil very well, meaning no reflux or annoying disgusting burps.

SeaDNA Seal Oil is also 100% Canadian from front to back and is of the highest quality.
Click here to learn more about the differences between seal oil and fish oil.


SeaDNA offers, along with our traditional softgels, a Lemon-Flavour Seal Oil that has been called the “best-tasting Omega-3” supplement on the market. Its versatility means you can add it to smoothies, juices, or your favourite salad dressing. One teaspoon a day is all you need.

SeaDNA’s line of Omega-3 products have all been certified as Natural Products by Health Canada and are 100% Canadian sourced and produced. 

To order:
For more information: or

Sources: 1 / Kaur G, et al. Docosapentaenoic acid (22: 5n-3): a review of its biological effects, 2011. 2 / Kelly, et al. The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. PubMed, 2011. 3 / Toshie Kanayasu-Toyoda, et al. Docosapentaenoic acid (22: 5, n-3), an elongation metabolite of eicosapentaenoic acid (20: 5, n-3), is a potent stimulator of endothelial cell migration in vitro pretreatment, 1996. 4 / Neil J. Mann, et al. Effects of seal oil and plasma on platelet parameters and plasma lipid levels in healthy subjects, epub, 2010. 5 / Evan J. H. Lewis, Bruce A. Perkins, Leif E. Lovblom, Richard P. Bazinet, Thomas M. S. Wolever, Vera Bril. Effect of omega-3 supplementation on neuropathy in type 1 diabetes. Neurology, 2017; 88 (24): 2294 DOI: 6/Centre hospitalier de l’Université de Montréal. “Treating depression with Omega-3: Encouraging results from largest clinical study.” ScienceDaily. ScienceDaily, 30 June 2010./Ann C. Skulas-Ray, * Michael R. Flock, Chesney K. Richter, William S. Harris, Sheila G. West 1.3 and Penny M. Kris-Etherton., Department of Nutritional Sciences, The Pennsylvania State University, University Park Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation, Nutrients (2015)/Calder PC. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition 83 (Suppl 6): 1505S-1519S./Caroline Morin, Pierre U Blier, and Samuel Fortin. Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model. Arthritis Res Ther. 2015; 17: 142./Jean-Charles Hogue, Contribution of cholesterol ester transfer protein to the heterogeneity of LDL particles in heterozygous familial hypercholesterolemia. 2004. Master of Science (M.Sc.) Laval University./Kremer JM, Lawrence DA, Petrillo GF, LL Litts, Mullaly PM, Rynes IR, Stocker RP, Parhami N, Greenstein NS, Fuchs BR, Mathur A, Robinson DR, R Sperling, Bigaouette J. 1995. Effects of high-dose fish rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Arthritis & Rheumatism 38 (8): 1107-1114./Kremer, J.M. 2000. n23 Fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 2000; 71 (suppl): 349S-51S/Lau CS, Morley KD, Belch JJ. 1993. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis – a double-blind placebo controlled study. British Journal of Rheumatology 32 (11): 982-989/